The present invention relates to the three dimensional solution structure
of receptor interacting protein dead domain (RIP DD), as well as the
identification and characterization of various binding active sites of
RIP DD. Also provided for by the present invention are methods of
utilizing the three dimensional structure for the design and selection of
potent and selective inhibitors of TNF signaling pathways.
